These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

622 related items for PubMed ID: 9420536

  • 1. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W, Nieuweboer-Krobotova L.
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [Abstract] [Full Text] [Related]

  • 2. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS, Palmer RA, Garibaldinos TM, Hawk JL.
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [Abstract] [Full Text] [Related]

  • 3. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
    Passeron T, Ostovari N, Zakaria W, Fontas E, Larrouy JC, Lacour JP, Ortonne JP.
    Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
    [Abstract] [Full Text] [Related]

  • 4. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
    Schallreuter KU, Krüger C, Würfel BA, Panske A, Wood JM.
    Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
    [Abstract] [Full Text] [Related]

  • 5. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A, Kanwar AJ, Parsad D, De D.
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [Abstract] [Full Text] [Related]

  • 6. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E, Taştan HB, Erbil AH, Sezer E, Koç E, Kurumlu Z.
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
    Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P.
    Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
    [Abstract] [Full Text] [Related]

  • 9. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
    Bhatnagar A, Kanwar AJ, Parsad D, De D.
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
    [Abstract] [Full Text] [Related]

  • 10. Treatment of vitiligo with broadband ultraviolet B and vitamins.
    Don P, Iuga A, Dacko A, Hardick K.
    Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
    [Abstract] [Full Text] [Related]

  • 11. Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies.
    El Mofty M, Mostafa W, Esmat S, Youssef R, Azzam O, Hunter N, El Hanafi G, Fawzi M.
    Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):6-11. PubMed ID: 16436175
    [Abstract] [Full Text] [Related]

  • 12. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS, Palmer RA, Garibaldinos TT, Hawk JL.
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [Abstract] [Full Text] [Related]

  • 13. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A, Lurz C, Hamm H, Bröcker EB, Hofmann UB.
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial.
    Schiener R, Brockow T, Franke A, Salzer B, Peter RU, Resch KL.
    Arch Dermatol; 2007 May; 143(5):586-96. PubMed ID: 17519218
    [Abstract] [Full Text] [Related]

  • 16. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.
    Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H.
    Arch Dermatol; 2004 Jun; 140(6):677-83. PubMed ID: 15210457
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S.
    J Dermatolog Treat; 2009 Jun; 20(1):14-8. PubMed ID: 18608735
    [Abstract] [Full Text] [Related]

  • 18. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
    Abdel-Naser MB, Hann SK, Bystryn JC.
    Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
    [Abstract] [Full Text] [Related]

  • 19. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
    Lee Y, Seo YJ, Lee JH, Park JK.
    Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
    [Abstract] [Full Text] [Related]

  • 20. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
    Sapam R, Agrawal S, Dhali TK.
    Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.